Your browser doesn't support javascript.
loading
A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer.
Garralda, E; Sukari, A; Lakhani, N J; Patnaik, A; Lou, Y; Im, S-A; Golan, T; Geva, R; Wermke, M; de Miguel, M; Palcza, J; Jha, S; Chaney, M; Abraham, A K; Healy, J; Falchook, G S.
Afiliación
  • Garralda E; Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Electronic address: egarralda@vhio.net.
  • Sukari A; Medical Oncology, Karmanos Cancer Institute, Detroit.
  • Lakhani NJ; Clinical Research, START Midwest, Grand Rapids.
  • Patnaik A; Clinical Research, START San Antonio, San Antonio.
  • Lou Y; Oncology, Mayo Clinic, Jacksonville, USA.
  • Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Golan T; Gastrointestinal Clinic, Sheba Medical Center, Tel-Aviv University, Tel Aviv.
  • Geva R; Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel.
  • Wermke M; NCT/UCC Early Clinical Trial Unit, Technical University, Dresden, Germany.
  • de Miguel M; Clinical Research, START-HM Sanchinarro Madrid, Madrid, Spain.
  • Palcza J; Clinical Research, Merck & Co., Inc., Rahway.
  • Jha S; Clinical Research, Merck & Co., Inc., Rahway.
  • Chaney M; Clinical Research, Merck & Co., Inc., Rahway.
  • Abraham AK; Clinical Research, Merck & Co., Inc., Rahway.
  • Healy J; Clinical Research, Merck & Co., Inc., Rahway.
  • Falchook GS; Drug Development, Sarah Cannon Research Institute at HealthONE, Denver, USA.
ESMO Open ; 7(6): 100639, 2022 12.
Article en En | MEDLINE | ID: mdl-36493599

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Antineoplásicos Inmunológicos Límite: Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Antineoplásicos Inmunológicos Límite: Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article